Asked to pay by a method with no recourse, by a supplier I had used twice before without being asked, which is what made me stop.
The bit I cannot resolve on my own is how people are thinking about the trade-off between reversibility and privacy, because you cannot have both.
Numbers rather than impressions, if you have them.
Short answer first, then the reasoning. Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third retelling.
LibrarianMeg said:Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third…
Right, and the exception is worth naming rather than left implied, because the exception is where people get into trouble.
If somebody has the primary source to hand I would rather cite it than paraphrase it.
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View Resultsmike.trainer_LA said:Asked to pay by a method with no recourse, by a supplier I had used twice before without being asked, which is what made me stop.
Same experience, arrived at from the opposite direction. Nothing to add that would improve it.
Adding the clinical framing, because it changes how the question reads. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.